These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38273019)

  • 1. Dihydroartemisinin-piperaquine effectiveness for seasonal malaria chemoprevention in settings with extended seasonal malaria transmission in Tanzania.
    Mwaiswelo R; Ngasala B; Chaky F; Molteni F; Mohamed A; Lazaro S; Samwel B; Mmbando BP
    Sci Rep; 2024 Jan; 14(1):2143. PubMed ID: 38273019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent preventive treatment of malaria delivered to primary schoolchildren provided effective individual protection in Jinja, Uganda: secondary outcomes of a cluster-randomized trial (START-IPT).
    Rehman AM; Maiteki-Sebuguzi C; Gonahasa S; Okiring J; Kigozi SP; Chandler CIR; Drakeley C; Dorsey G; Kamya MR; Staedke SG
    Malar J; 2019 Sep; 18(1):318. PubMed ID: 31533845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.
    Tagbor H; Antwi GD; Acheampong PR; Bart Plange C; Chandramohan D; Cairns M
    Trop Med Int Health; 2016 Feb; 21(2):224-35. PubMed ID: 26578353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
    Taylor SM; Korwa S; Wu A; Green CL; Freedman B; Clapp S; Kirui JK; O'Meara WP; Njuguna FM
    PLoS Med; 2022 Oct; 19(10):e1004104. PubMed ID: 36215323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Field Trial to Assess the Safety and Efficacy of Dihydroartemisinin-Piperaquine for Seasonal Malaria Chemoprevention in School-Aged Children in Bandiagara, Mali.
    Traore K; Coulibaly D; Kone AK; Guindo B; Traore S; Kouriba K; Djimde M; Thera MA
    J Infect Dis; 2024 Jan; 229(1):189-197. PubMed ID: 37682871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial.
    Bigira V; Kapisi J; Clark TD; Kinara S; Mwangwa F; Muhindo MK; Osterbauer B; Aweeka FT; Huang L; Achan J; Havlir DV; Rosenthal PJ; Kamya MR; Dorsey G
    PLoS Med; 2014 Aug; 11(8):e1001689. PubMed ID: 25093754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali.
    Diawara F; Steinhardt LC; Mahamar A; Traore T; Kone DT; Diawara H; Kamate B; Kone D; Diallo M; Sadou A; Mihigo J; Sagara I; Djimde AA; Eckert E; Dicko A
    Malar J; 2017 Aug; 16(1):325. PubMed ID: 28797263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years old in Malawi: a protocol for a cluster randomized trial.
    Gondwe T; Robberstad B; Mukaka M; Lange S; Blomberg B; Phiri K
    BMC Pediatr; 2018 Jul; 18(1):238. PubMed ID: 30029620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso.
    Zongo I; Milligan P; Compaore YD; Some AF; Greenwood B; Tarning J; Rosenthal PJ; Sutherland C; Nosten F; Ouedraogo JB
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4387-96. PubMed ID: 25918149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hybrid effectiveness-implementation study protocol to assess the effectiveness and chemoprevention efficacy of implementing seasonal malaria chemoprevention in five districts in Karamoja region, Uganda.
    Kajubi R; Ainsworth J; Baker K; Richardson S; Bonnington C; Rassi C; Achan J; Magumba G; Rubahika D; Nabakooza J; Tibenderana J; Nuwa A; Opigo J
    Gates Open Res; 2023; 7():14. PubMed ID: 38196920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation research of a cluster randomized trial evaluating the implementation and effectiveness of intermittent preventive treatment for malaria using dihydroartemisinin-piperaquine on reducing malaria burden in school-aged children in Tanzania: methodology, challenges, and mitigation.
    Makenga G; Seth MD; Baraka V; Mmbando BP; Challe DP; Francis F; Mhina A; Minja DTR; Chiduo M; Mandara C; Liheluka E; Gesase S; Segeja M; Mtove G; Kamugisha M; Lusasi A; Chacky F; David A; Thawer S; Mohamed A; Lazaro S; Molteni F; Nkayamba A; Van Geertruyden JP; Lusingu JPA
    Malar J; 2023 Jan; 22(1):7. PubMed ID: 36609279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydroartemisinin-Piperaquine Chemoprevention and Malaria Incidence After Severe Flooding: Evaluation of a Pragmatic Intervention in Rural Uganda.
    Boyce RM; Hollingsworth BD; Baguma E; Xu E; Goel V; Brown-Marusiak A; Muhindo R; Reyes R; Ntaro M; Siedner MJ; Staedke SG; Juliano JJ; Mulogo EM
    Clin Infect Dis; 2022 Jul; 74(12):2191-2199. PubMed ID: 34499116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malaria Chemoprevention in the Postdischarge Management of Severe Anemia.
    Kwambai TK; Dhabangi A; Idro R; Opoka R; Watson V; Kariuki S; Kuya NA; Onyango ED; Otieno K; Samuels AM; Desai MR; Boele van Hensbroek M; Wang D; John CC; Robberstad B; Phiri KS; Ter Kuile FO
    N Engl J Med; 2020 Dec; 383(23):2242-2254. PubMed ID: 33264546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis.
    Gutman J; Kovacs S; Dorsey G; Stergachis A; Ter Kuile FO
    Lancet Infect Dis; 2017 Feb; 17(2):184-193. PubMed ID: 27865890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial.
    Jagannathan P; Kakuru A; Okiring J; Muhindo MK; Natureeba P; Nakalembe M; Opira B; Olwoch P; Nankya F; Ssewanyana I; Tetteh K; Drakeley C; Beeson J; Reiling L; Clark TD; Rodriguez-Barraquer I; Greenhouse B; Wallender E; Aweeka F; Prahl M; Charlebois ED; Feeney ME; Havlir DV; Kamya MR; Dorsey G
    PLoS Med; 2018 Jul; 15(7):e1002606. PubMed ID: 30016328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High cure rates and tolerability of artesunate-amodiaquine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania.
    Mandara CI; Francis F; Chiduo MG; Ngasala B; Mandike R; Mkude S; Chacky F; Molteni F; Njau R; Mohamed A; Warsame M; Ishengoma DS
    Malar J; 2019 Mar; 18(1):99. PubMed ID: 30909922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of community-level effects of intermittent preventive treatment for malaria in schoolchildren in Jinja, Uganda (START-IPT trial): a cluster-randomised trial.
    Staedke SG; Maiteki-Sebuguzi C; Rehman AM; Kigozi SP; Gonahasa S; Okiring J; Lindsay SW; Kamya MR; Chandler CIR; Dorsey G; Drakeley C
    Lancet Glob Health; 2018 Jun; 6(6):e668-e679. PubMed ID: 29661635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia.
    Dabira ED; Soumare HM; Conteh B; Ceesay F; Ndiath MO; Bradley J; Mohammed N; Kandeh B; Smit MR; Slater H; Peeters Grietens K; Broekhuizen H; Bousema T; Drakeley C; Lindsay SW; Achan J; D'Alessandro U
    Lancet Infect Dis; 2022 Apr; 22(4):519-528. PubMed ID: 34919831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial.
    Cissé B; Ba EH; Sokhna C; NDiaye JL; Gomis JF; Dial Y; Pitt C; NDiaye M; Cairns M; Faye E; NDiaye M; Lo A; Tine R; Faye S; Faye B; Sy O; Konate L; Kouevijdin E; Flach C; Faye O; Trape JF; Sutherland C; Fall FB; Thior PM; Faye OK; Greenwood B; Gaye O; Milligan P
    PLoS Med; 2016 Nov; 13(11):e1002175. PubMed ID: 27875528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional status of children under five years old involved in a seasonal malaria chemoprevention study in the Nanyumbu and Masasi districts in Tanzania.
    Mmbando BP; Mwaiswelo RO; Chacky F; Molteni F; Mohamed A; Lazaro S; Ngasala B
    PLoS One; 2022; 17(4):e0267670. PubMed ID: 35486649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.